Antimicrobial resistance Flashcards
AMR consequences on animal and public health
Increased patient mortality and morbidity
Risk of zoonotic transmission
AMR Economic consequences
More visits, laboratory test and therapies
Prolonged hospitalization (companion animals)
Reduced weight gain (food animals)
Loss of customers/reputation by veterinarians
Costs for hospital/farm decontamination
Costs for surveillance and intervention program
Microbiological definition AMR
Resistance is the property of bacterial strains to survive at higher antibiotic concentration compared with the wild type population (bacterial population that does not contain any resistance gene or mutation conferring resistance within the species)
The ability of microbes to grow in the presence of a drug that would normally kill them or limit their growth
Clinical definition AMR
Resistance is the bacterial ability to survive antimicrobial therapy and cause therapeutic failure
One health dimension of AMR
Spread between animals
Spread between animals and humans including via food
Spread between humans
Spread in environment, including via contaminated water and fertilizer
Different antimicrobial resistance strategies
To stop the antibiotic from reaching its target at high enough concentration
To modify or bypass the target that the antibiotic inhibits
To stop the antibiotic from reaching target
Efflux pumps
Decrease permeability of the membrane that surrounds the bacterial cell
Destroy the antibiotic: production of bacterial enzymes (B-lactamase)
Modify the antibiotic by adding different chemical groups to antibiotics
To modify/bypass the target
Camouflage the target
Express alternative proteins
Reprogram target: some bacteria can produce a different variant of a structure it needs
-vancomycin-resistant bacteria make a different cell wall compared to susceptible bacteria
Intrinsic resistance
Naturally acquired trait
Species or genus specific
Acquired resistance
By mutation in the existing DNA of the organism
By acquisition of new DNA via transformation, transduction or conjugation
Antibiotic selection
Bacteria that have acquired resistance keep passing it to other bacteria. At the same time, antimicrobials keep killing bacteria that have no resistance, increasing the share of resistant bacteria
Methicillin Resistant- Staphylococcus aureus, MRSA
Gram + skin commensal of many animals and humans (S. aureus)
Acquired resistance gene (mecA) encoding for new penicillin-binding proteins with low affinity to most B-lactams (penicillins and cephalosporins)
Major role in nosocomial infections
-community-acquired MRSA
- Hospital-acquired MRSA
-Livestock-acquired MRSA
Methicillin Resistant- Staphylococcus pseudintermedius, MRSP
Gram + skin commensal of dogs
Acquired resistance gene (mecA), similar to MRSA
Approximately 70% of cases are skin and wound postsurgical infections acquired in the clinic (nosocomial infections)
Some MRSP strains are multi-drug resistant bacteria (MDR) and may be resistant to all antibiotics licensed for veterinary use
Extended Spectrum Beta Lactamase producing enterobacteriaceae, ESBL
Gram - bacteria producing an enzyme that can hydrolyze/inactivate most B-lactams, except Carbapenems
Risk of foodborne transmission is higher for ESBL-producing E coli
-gut commensal
-may transfer from animals to humans via consumption of meat
-Upon ingestion, may colonize the gut and transfer ESBL-encoding plasmids to resident e. coli
Antimicrobial dilemma
Antimicrobials are essential in the cure of infectious diseases in humans and animals
Antibiotic selection leads to reduced efficacy over time
AMR cannot be eradicated but only controlled through rational animicrobial use